LOS ANGELES — Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book ...

A rash is among the most common symptoms of Kawasaki disease. Kawasaki disease is an inflammatory condition affecting blood vessels that commonly develops in children under five. Kawasaki disease is a ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? In a recent Instagram post, one prominent New York City dermatologist exposed ...

A new study in The New England Journal of Medicine revealed that the PRIMA brain computer interface (BCI) retinal implant helped people with advanced age-related macular degeneration regain some ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

The device could help a million people with a severe form of macular degeneration to be able to see enough to read. By Gina Kolata For the first time, researchers restored some vision to people with a ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching 0.2 ...

Please provide your email address to receive an email when new articles are posted on . Central retinal thickness and macular volume increased at 2 months postop but returned to preop levels at 6 ...

A 58-year-old man presented with acute hemiparesis. His past medical history included active cigarette and cannabis smoking, well-controlled hypertension, dyslipidemia, presbycusis, traumatic ...

The prescription of metformin was associated neither with the development of age-related macular degeneration (AMD) in participants without the condition nor with progression to advanced forms of the ...

Scientists have developed a new eyedrop that can ferry protective compounds all the way to the retina, paving the way for a less-invasive injection-free method of managing sight-stealing diseases such ...